GLOW Stock Overview
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Glow Lifetech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.06 |
| 52 Week High | CA$0.14 |
| 52 Week Low | CA$0.02 |
| Beta | 2.3 |
| 11 Month Change | 9.09% |
| 3 Month Change | -7.69% |
| 1 Year Change | 100.00% |
| 33 Year Change | -73.91% |
| 5 Year Change | n/a |
| Change since IPO | -90.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| GLOW | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 20.0% | -4.9% | 0.04% |
| 1Y | 100.0% | -32.7% | 22.7% |
Return vs Industry: GLOW exceeded the Canadian Pharmaceuticals industry which returned -32% over the past year.
Return vs Market: GLOW exceeded the Canadian Market which returned 23.3% over the past year.
Price Volatility
| GLOW volatility | |
|---|---|
| GLOW Average Weekly Movement | 26.4% |
| Pharmaceuticals Industry Average Movement | 11.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: GLOW's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: GLOW's weekly volatility has decreased from 53% to 26% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron.
Glow Lifetech Corp. Fundamentals Summary
| GLOW fundamental statistics | |
|---|---|
| Market cap | CA$7.29m |
| Earnings (TTM) | -CA$1.43m |
| Revenue (TTM) | CA$554.47k |
13.1x
P/S Ratio-5.1x
P/E RatioIs GLOW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GLOW income statement (TTM) | |
|---|---|
| Revenue | CA$554.47k |
| Cost of Revenue | CA$402.30k |
| Gross Profit | CA$152.17k |
| Other Expenses | CA$1.59m |
| Earnings | -CA$1.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 27.44% |
| Net Profit Margin | -258.66% |
| Debt/Equity Ratio | 207.0% |
How did GLOW perform over the long term?
See historical performance and comparison